A Competitor Is Taking Our Customers
in Insurance Brokers

The short answer

Losing to a competitor is a positioning question far more often than a commission one, and the two need opposite responses. Insurance brokers carry a specific bind here — 71 percent of revenue flows through carrier commissions while shifting an incremental 8 percent to fees would require replacing 142 renewal accounts and cut near-term margin by 1.8 to 2.3 points. Until that is priced, 19.0 will keep moving for reasons nobody can attribute, and the debate about win rate by segment will stay a matter of opinion.

When a competitor starts winning, the first explanation offered inside the brokerage is always commission rates. It is occasionally true. More often the competitor has picked a narrower promise such as captive feasibility or risk-control and is beating you inside it, which looks like commission to the producers because commission is the last thing discussed before a loss.

The distinction matters because the responses are incompatible. If it is genuinely commission, you either match it and reprice the whole book or you accept the loss of that segment. If it is positioning, matching commission funds their advantage while destroying your margin, and shifting an incremental share to fees would require replacing 142 renewal accounts and cut near-term margin by 1.8 to 2.3 points.

The way to tell is unglamorous: the reasons recorded on the last twenty losses, segmented. A commission problem shows up everywhere. A positioning problem clusters. Losses concentrate where the 91.2 renewal retention figure drops while 19.0 and 31 mark the affected segments, and 664 accounts show the pattern.

How to tell this is actually your problem

These three together are the signature. One on its own usually points somewhere else.

✓ Losses concentrate in accounts seeking captive feasibility or specific risk-control rather than spreading evenly across the 47.8 million dollars book
✓ Producers ask for authority to cut standard commissions or contingent commissions rather than for proof on risk-control or captive feasibility
✓ The competitor is smaller and more specific than you, winning on narrow cases while your overall retention holds at 91.2

The move that usually makes it worse. Meeting the commission and keeping the positioning, which loses the margin and the argument at the same time.

Who this is for — and who it is not

It is for you if you run or finance an insurance broker and losses concentrate in one segment or one use case rather than spreading evenly. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

What this looks like when the analysis is actually run

Below is an excerpt from a real run of this analysis on an insurance broker. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.

The subject is Kesterline Risk Partners, a sample company profile used for testing rather than a customer — 47.8 million dollars in total revenue from commissions and fees.

This is one move out of a full analysis. Read a complete report — every page, no email required.

What the engine does with this question

This question routes to Competitive Benchmarking & Positioning, one of 29 engagements the platform runs. For insurance brokers it works through 19.0, 91.2, 664 and 31, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.

Questions people ask about this

Should I match a competitor who undercuts me?

Only if you can serve that segment at their price and still make money, and only if you are willing to reprice the customers who already pay you more. A selective match is usually a promise you cannot keep once the market notices.

How do I compete against someone better funded?

On specificity, not on breadth. A better-funded competitor can outspend you everywhere and cannot out-focus you in one place, which is why narrowing the promise usually beats broadening the feature set.

What if we are genuinely losing on product?

Then the honest answer is a product decision with a timeline and a cost, not a marketing response. The damaging outcome is spending a year on messaging for a gap that messaging cannot close.

Is this different in insurance brokers than in other industries?

Materially, yes. 71 percent of revenue flows through carrier commissions while shifting an incremental 8 percent to fees would require replacing 142 renewal accounts and cut near-term margin by 1.8 to 2.3 points — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 19.0, 91.2, 664, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for an insurance broker?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 19.0 and 91.2. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.